Lombard Odier Asset Management (Switzerland)’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-607,760
| Closed | -$1.91M | – | 422 |
|
|
2022
Q4 | $1.91M | Sell |
607,760
-74,540
| -11% | -$234K | 0.15% | 125 |
|
|
2022
Q3 | $3.34M | Sell |
682,300
-96,469
| -12% | -$473K | 0.28% | 82 |
|
|
2022
Q2 | $3.22M | Sell |
778,769
-81,933
| -10% | -$339K | 0.27% | 90 |
|
|
2022
Q1 | $5M | Sell |
860,702
-679,292
| -44% | -$3.95M | 0.39% | 62 |
|
|
2021
Q4 | $11.6M | Buy |
1,539,994
+130,258
| +9% | +$977K | 0.74% | 50 |
|
|
2021
Q3 | $12.7M | Buy |
1,409,736
+202,795
| +17% | +$1.83M | 0.79% | 54 |
|
|
2021
Q2 | $14.4M | Buy |
1,206,941
+358,512
| +42% | +$4.29M | 0.73% | 53 |
|
|
2021
Q1 | $10.6M | Buy |
+848,429
| New | +$10.6M | 0.71% | 52 |
|